Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820100200010085
Korean Journal of Clinical Pharmacy
2010 Volume.20 No. 1 p.85 ~ p.87
Early-stage Diagnosis of Bladder Carcinoma by a Clinical Pharmacist¡¯s Effective Anti-coagulation Service in a Patient with Anticoagulation Anticoagulation
An Sung-Sim

Bang Joon-Seok
La Hyen-O
Abstract
Recently, the prevalence of bladder cancer is increasing in the Korean society. As the risk factors of bladder carcinoma are variable, the early-stage diagnosis is regarded the best preventive practice. Hematuria is a specific sign of the malignancy as well as a kind of various medication-related adverse reactions. Some anti-coagulation therapy can cause bleedings including hematuria to the patients with cardiovascular diseases such as paroxysmal atrial fibrillation (PAF). Therefore, to the clinical pharmacists working in the anti-coagulation services (ACS), a closer monitoring of patients can give an opportunity to find certain ailments unexpectedly. In this case, a patient with PAF had episodes of sporadic hematuria in the course of warfarin therapy even though with its low levels of INR. An ACS pharmacist found a discrepancy between the bleeding symptoms and INR values, and recommended properly the patient to refer urologist. Fortunately, an early-stage of bladder carcinoma was found then followed by an excision performed to the lesion. Therefore, alert-minded and precise monitoring done by ACS pharmacist could optimize the therapeutic outcomes as well as increase the quality of life of the patient.
KEYWORD
bladder carcinoma, hematuria, anticoagulation, warfarin, INR, ACS
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)